Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose furosemide plus aminophylline in septic shock
ChiCTR2000040822Phase 4Completed
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of furosemide and aminophylline in septic shock and acute kidney failure (AKF) (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoints: Serum creatinine (Scr), Blood urea nitrogen (BUN) and 3 more. Started Jan 2017; status: completed.
02
Drugs
furosemideaminophylline
03
Conditions
septic shockacute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2000040822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040822.